K2 toxicity: fatal case of psychiatric complications following AM2201 exposure. - Wikidata - awgldk - TriplyDB

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

http://www.wikidata.org/entity/Q35057032

about

NPS: Medical Consequences Associated with Their Intake Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Using poisons information service data to assess the acute harms associated with novel psychoactive substances.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with hum Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Novel psychoactive substances of interest for psychiatry.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.Toxicology and management of novel psychoactive drugs.The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.Acute effects of synthetic cannabinoids: Update 2015.Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.Analysis of AM-2201 and metabolites in a drugs and driving case.Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11

P2860

Q28276182-D93C5306-C9BE-40C4-AF3B-2F72843B5D81 Q28540537-2C4975D6-AD55-4B73-9453-73E106687509 Q30821795-5D8C236D-140F-44DB-A0B9-EECF05218ECA Q33908169-3AD46AA1-A365-4C12-A02F-AE29FCDE637A Q34156299-B8798379-3522-43C1-B8F7-05E7F1225982 Q34493135-EFBED48B-9A45-474F-BD97-8B59EEED5DA1 Q34501742-7E853D93-3816-4482-8B61-4C4E616AFAA6 Q34514221-F31F77E6-05F2-4636-92F4-31AAAAD3EFA8 Q34617484-DC37FC53-F9D5-46B2-9E43-5DE1B4CA8B75 Q34667835-0027A391-22CB-42FA-B95C-A70FF89E9340 Q35254099-3C6B2370-A180-4323-8215-B4BEC4B84E77 Q35917163-6DAAAC3C-3E52-4FF2-AED1-3E787E97D152 Q36950560-0734EDDD-A774-46E2-B161-B35E139C500C Q38254814-6DF734E5-3F1A-4669-ACB2-5722967DA79D Q38317405-779E841E-D62F-48FA-9671-59D14C756410 Q38411456-E6F02042-9EE4-49C1-AEE7-708902B81971 Q38974969-BE5711DC-8F30-48B4-8A2F-5AA0FB8A7D55 Q39052265-706CAF71-7C48-4588-B115-06E48407B0A4 Q39196884-5E85F9B2-9391-41D5-A68E-EDA99CF984CC Q45066806-A09A0CB7-837D-49DE-8372-9A9AF96ABEE2 Q47203043-00515FEF-0113-4134-BA75-3BFA25332702 Q48301733-9BB1869B-C39E-4D26-BAAA-B633DE6233E0 Q51100761-E1DB4ABC-1DBE-47E0-B89A-9B13572A304E Q57814871-D005FC6C-7F73-49FA-8552-E211C7DBDCBA

P2860

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

http://www.wikidata.org/entity/Q35057032

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@ast

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@en

type

label

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@ast

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@en

prefLabel

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@ast

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@en

P1433

Q35057032-C6DA8CA2-77BC-4C91-8F6D-6FB724B6C435

P1476

Q35057032-5EDEEE6B-D114-463F-9001-F630620EA78B

P2093

Q35057032-0529B33A-0D1B-4EC6-91E4-C4B8CC076F0B

Q35057032-20569C9C-78C8-49EA-88AB-D46C05B1F190

Q35057032-33167FDC-A206-405B-91CB-103C89ECE698

Q35057032-4C122AE6-ABF0-4C95-9EBC-607D70555692

Q35057032-5EB30158-C490-410F-A864-C711246B937F

Q35057032-66D808E8-E010-4E71-984B-E7A484568516

Q35057032-772D0914-4B34-4AEA-A28C-F77F799927E2

Q35057032-DEB99B4D-FA5D-4B1A-87A1-36574E7D6170

P2860

Q35057032-03CF984C-5872-4EFC-B645-5993E70D034E

Q35057032-063625EE-B276-4747-BE05-BA8F07079B6A

Q35057032-1D1CDF25-C90A-4419-B361-17132B20911C

Q35057032-34DB0EBE-1E89-42D7-9059-0F4FE7E783D4

Q35057032-4CA6D050-7FE9-41CE-9AE0-E9B0F1834DA7

Q35057032-5EBB5CD3-2DEA-46C9-B39F-41D8ECBC8F41

Q35057032-69599999-CB58-484C-8573-34DA200F5766

Q35057032-797C6AC9-BA11-49C8-B2DB-FAF82A9886F2

Q35057032-7FAB8AC8-3557-4FCD-B727-F3796B1B34EC

Q35057032-808E8DC0-5A49-4988-94A9-ABD0AD769F67

P304

Q35057032-65426B0A-969B-49A6-8B78-F7E5E798AD52

P31

Q35057032-DC9B3D61-62C5-42D1-AF20-F08692CB1926

P356

Q35057032-57C7E1CC-E628-4B0E-B14B-EF25EF95642F

P433

Q35057032-4CF4BF9A-9CCE-4610-99A2-7B10A42813FD

P478

Q35057032-A90DE0D8-E736-42C4-809D-A325BB785CF4

P577

Q35057032-8228A616-D7AD-443E-9615-0C5B2920DFB9

P698

Q35057032-04E9D2E2-4E2D-45B5-B13F-49B62499BC7C

P932

Q35057032-F2149EAC-F303-402C-AEB5-AAB6CAB27A07

P356

1556-4029.12216

P1433

Journal of Forensic Sciences

P1476

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

@en

P2093

Amy L Patton

http://www.w3.org/2001/XMLSchema#string

Anna Radominska-Pandya

http://www.w3.org/2001/XMLSchema#string

Charles Kokes

http://www.w3.org/2001/XMLSchema#string

Cindy L Moran

http://www.w3.org/2001/XMLSchema#string

Jeffery H Moran

http://www.w3.org/2001/XMLSchema#string

Keith R McCain

http://www.w3.org/2001/XMLSchema#string

Krishna C Chimalakonda

http://www.w3.org/2001/XMLSchema#string

Laura P James

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond THC: The New Generation of Cannabinoid Designer Drugs

Withdrawal phenomena and dependence syndrome after the consumption of "spice gold"

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids

Spice drugs as a new trend: mode of action, identification and legislation.

Synthetic cannabinoid JWH-018 and psychosis: an explorative study.

Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine

Severe toxicity following synthetic cannabinoid ingestion.

Spice: a never ending story?

College students and use of K2: an emerging drug of abuse in young persons

P304

1676-1680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1556-4029.12216

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23822805

http://www.w3.org/2001/XMLSchema#string

P932

4319529

http://www.w3.org/2001/XMLSchema#string